NEW YORK (360Dx) –  A World Health Organization panel has approved Atomo Diagnostics' HIV self-test, making it eligible for procurement by organizations that can access Global Fund and Unitaid resources, Atomo announced today.

The Atomo HIV Self Test was approved by WHO's Expert Review Panel for Diagnostics (ERP-D), a process to accelerate access to diagnostic products in advance of approvals through the WHO prequalification process. As a result, the test can be procured by organizations accessing Global Fund and/or Unitaid funding HIV self-test pilot programs, Atomo said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.